Strain identifier

BacDive ID: 10471

Type strain: No

Species: Neisseria gonorrhoeae

Strain Designation: 89-018314, F-18, P935

Strain history: CIP <- 2001, CCM <- C. Thornsberry: strain F-18 <- J.E. Martin

NCBI tax ID(s): 485 (species)

For citation purpose refer to the digital object identifier (doi) of the current version.
Archive
version 8.1 (current version):
version 8:
version 7.1:
version 7:
version 6:
version 5:
version 4.1:
version 4:
version 3:
version 2.1:
version 2:
version 1:
version 8.1 (current version)

General

@ref: 3508

BacDive-ID: 10471

DSM-Number: 9189

keywords: genome sequence, 16S sequence, Bacteria, microaerophile, mesophilic, Gram-negative

description: Neisseria gonorrhoeae 89-018314 is a microaerophile, mesophilic, Gram-negative bacterium of the family Neisseriaceae.

NCBI tax id

  • NCBI tax id: 485
  • Matching level: species

strain history

@refhistory
3508<- ATCC; ATCC 49226 <- C. Thornsberry; F-18 <- J. Martin; CDC 10.001
119706CIP <- 2001, CCM <- C. Thornsberry: strain F-18 <- J.E. Martin

doi: 10.13145/bacdive10471.20230509.8.1

Name and taxonomic classification

LPSN

  • @ref: 20215
  • description: domain/bacteria
  • keyword: phylum/pseudomonadota
  • domain: Bacteria
  • phylum: Pseudomonadota
  • class: Betaproteobacteria
  • order: Neisseriales
  • family: Neisseriaceae
  • genus: Neisseria
  • species: Neisseria gonorrhoeae
  • full scientific name: Neisseria gonorrhoeae (Zopf 1885) Trevisan 1885 (Approved Lists 1980)
  • synonyms

    • @ref: 20215
    • synonym: Merismopedia gonorrhoeae

@ref: 3508

domain: Bacteria

phylum: Proteobacteria

class: Betaproteobacteria

order: Neisseriales

family: Neisseriaceae

genus: Neisseria

species: Neisseria gonorrhoeae

full scientific name: Neisseria gonorrhoeae (Zopf 1885) Trevisan 1885

strain designation: 89-018314, F-18, P935

type strain: no

Morphology

cell morphology

@refgram stainconfidencecell shapemotility
69480negative99.99
119706negativecoccus-shapedno

colony morphology

@reftype of hemolysisincubation period
3508gamma1-2 days
119706

Culture and growth conditions

culture medium

@refnamegrowthlinkcomposition
3508COLUMBIA BLOOD MEDIUM (DSMZ Medium 693)yeshttps://mediadive.dsmz.de/medium/693Name: COLUMBIA BLOOD MEDIUM (DSMZ Medium 693) Composition: Defibrinated sheep blood 50.0 g/l Columbia agar base
36023MEDIUM 10 - Chocolate medium for Actinobacillus pleuropneumoniae, Capnocytophaga cynodegmi, Haemophilus and NeisseriayesDistilled water make up to (1000.000 ml);Columbia agar (39.000 g);Horseblood (100.000 ml);PolyVitex mischung (10.000 ml)
119706CIP Medium 10yeshttps://catalogue-crbip.pasteur.fr/fiche_milieu.xhtml?crbip=10

culture temp

@refgrowthtypetemperaturerange
3508positivegrowth37mesophilic
36023positivegrowth37mesophilic
48390positivegrowth36mesophilic
119706positivegrowth25-37mesophilic
119706nogrowth41thermophilic

Physiology and metabolism

oxygen tolerance

@refoxygen tolerance
3508microaerophile
48390microaerophile

spore formation

@refspore formationconfidence
69481no100
69480no100

metabolite utilization

@refChebi-IDmetaboliteutilization activitykind of utilization tested
119706606565hippurate-hydrolysis
11970617632nitrate-builds gas from
11970617632nitrate-reduction
11970616301nitrite-builds gas from
11970616301nitrite-reduction
6837717306maltose-builds acid from
6837717992sucrose-builds acid from
6837718257ornithine-degradation
6837716199urea-hydrolysis
6837727897tryptophan-energy source

metabolite production

@refChebi-IDmetaboliteproduction
6837735581indoleno
11970635581indoleno

metabolite tests

  • @ref: 68377
  • Chebi-ID: 35581
  • metabolite: indole
  • indole test: -

enzymes

@refvalueactivityec
3508catalase+1.11.1.6
3508cytochrome-c oxidase+1.9.3.1
68377tryptophan deaminase-4.1.99.1
68377alkaline phosphatase-3.1.3.1
68377lipase-
68377urease-3.5.1.5
68377ornithine decarboxylase-4.1.1.17
119706oxidase+
119706beta-galactosidase+3.2.1.23
119706alcohol dehydrogenase-1.1.1.1
119706gelatinase-
119706amylase-
119706DNase-
119706caseinase-3.4.21.50
119706catalase+1.11.1.6
119706tween esterase-
119706gamma-glutamyltransferase-2.3.2.2
119706lecithinase-
119706lipase-
119706lysine decarboxylase-4.1.1.18
119706ornithine decarboxylase-4.1.1.17
119706protease-
119706urease-3.5.1.5
68382alkaline phosphatase-3.1.3.1
68382esterase (C 4)+
68382esterase lipase (C 8)+
68382lipase (C 14)-
68382leucine arylamidase+3.4.11.1
68382valine arylamidase-
68382cystine arylamidase-3.4.11.3
68382trypsin-3.4.21.4
68382alpha-chymotrypsin-3.4.21.1
68382acid phosphatase+3.1.3.2
68382naphthol-AS-BI-phosphohydrolase-
68382alpha-galactosidase-3.2.1.22
68382beta-galactosidase-3.2.1.23
68382beta-glucuronidase-3.2.1.31
68382alpha-glucosidase-3.2.1.20
68382beta-glucosidase-3.2.1.21
68382N-acetyl-beta-glucosaminidase-3.2.1.52
68382alpha-mannosidase-3.2.1.24
68382alpha-fucosidase-3.2.1.51

API zym

@refControlAlkaline phosphataseEsteraseEsterase LipaseLipaseLeucine arylamidaseValine arylamidaseCystine arylamidaseTrypsinalpha- ChymotrypsinAcid phosphataseNaphthol-AS-BI-phosphohydrolasealpha- Galactosidasebeta- Galactosidasebeta- Glucuronidasealpha- Glucosidasebeta- GlucosidaseN-acetyl-beta- glucosaminidasealpha- Mannosidasealpha- Fucosidase
119706--++-+----+---------

API NH

@refPENGLUFRUMALSACODCURELIPPALbeta GALProAGGTIND
3508-+--------++-
48390-+--------+--
3508+--------+---
3508+--------+---
3508+--------+---
3508+--------+---
3508+--------+---
3508-++/--------+--
3508-+--------+--
3508-+--------+--
3508-+--------+--
3508-+--------+--
3508-+--------+--
3508-+--------+--

Isolation, sampling and environmental information

taxonmaps

  • @ref: 69479
  • File name: preview.99_52.png
  • url: https://microbeatlas.org/index.html?action=taxon&taxon_id=90_15355;96_42;97_44;98_48;99_52&stattab=map
  • Last taxonomy: Neisseria gonorrhoeae subclade
  • 16S sequence: GU395613
  • Sequence Identity:
  • Total samples: 3694
  • soil counts: 26
  • aquatic counts: 208
  • animal counts: 3447
  • plant counts: 13

Safety information

risk assessment

@refbiosafety levelbiosafety level comment
35082Risk group (German classification)
1197062Risk group (French classification)

Sequence information

16S sequences

@refdescriptionaccessionlengthdatabaseNCBI tax ID
20218Neisseria gonorrhoeae strain ATCC 49226 16S ribosomal RNA gene, complete sequenceGU3956121544ena485
20218Neisseria gonorrhoeae strain 49226mut_SPC 16S ribosomal RNA gene, complete sequenceGU3956131544ena485

Genome sequences

@refdescriptionaccessionassembly leveldatabaseNCBI tax ID
66792Neisseria gonorrhoeae ATCC 49226GCA_016803895chromosomencbi485
66792Neisseria gonorrhoeae ATCC 49226GCA_001997645scaffoldncbi485
66792Neisseria gonorrhoeae strain ATCC 49226485.9871completepatric485
66792Neisseria gonorrhoeae strain ATCC 49226485.877wgspatric485
66792Neisseria gonorrhoeae strain ATCC49226485.866wgspatric485
66792Neisseria gonorrhoeae ATCC 49226GCA_025171215completencbi485
66792Neisseria gonorrhoeae strain ATCC 49226485.18004completepatric485

Genome-based predictions

predictions

traitpredictionconfidencetraining_data
spore-formingno100no
gram-positiveno98.302no
anaerobicno97.935yes
halophileno61.407no
spore-formingno97.653no
glucose-utilyes64.43no
aerobicno93.753no
thermophileno98.801yes
motileno84.291no
flagellatedno89.468no
glucose-fermentno90.579no

External links

@ref: 3508

culture collection no.: DSM 9189, ATCC 49226, CCUG 26213, CDC 10.001, CIP 107031, CCM 4500, CNCTC 5194

straininfo link

  • @ref: 79748
  • straininfo: 42367

literature

topicPubmed-IDtitleauthorsjournalDOIyearmeshtopic2
Pathogenicity1316371MIC and disk diffusion quality control guidelines for Neisseria gonorrhoeae susceptibility tests of cefdinir, cefetamet, CI-960, fleroxacin, lomefloxacin, and temafloxacin.Erwin ME, Jones RN, Koontz FP, Gerlach EH, Murray PR, Washington JAJ Clin Microbiol10.1128/jcm.30.5.1317-1319.19921992Anti-Infective Agents/*pharmacology, Cefdinir, Ceftizoxime/*analogs & derivatives/pharmacology, Cephalosporins/*pharmacology, Diffusion, Fleroxacin/*pharmacology, *Fluoroquinolones, Microbial Sensitivity Tests/*standards, Neisseria gonorrhoeae/*drug effects, Quality Control, Quinolones/*pharmacology
Pathogenicity1500533Proposed interpretive criteria and quality control parameters for testing susceptibility of Neisseria gonorrhoeae to beta-lactam-clavulanate combinations.Fuchs PC, Barry AL, Baker CN, Murray PR, Washington JAJ Clin Microbiol10.1128/jcm.30.8.2191-2194.19921992Amoxicillin/administration & dosage, Anti-Bacterial Agents/*administration & dosage, Clavulanic Acid, Clavulanic Acids/*administration & dosage, Drug Therapy, Combination/administration & dosage, Evaluation Studies as Topic, Gonorrhea/drug therapy, Humans, Microbial Sensitivity Tests/*methods/standards, Neisseria gonorrhoeae/*drug effects/isolation & purification, Quality Control, Ticarcillin/administration & dosageEnzymology
Pathogenicity1572960Proposed interpretive criteria and quality control parameters for ofloxacin susceptibility testing of Neisseria gonorrhoeae.Fuchs PC, Barry AL, Baker C, Murray PR, Washington JAJ Clin Microbiol10.1128/jcm.30.4.1024-1026.19921992Drug Resistance, Microbial, Evaluation Studies as Topic, Humans, Microbial Sensitivity Tests/*methods/standards, Neisseria gonorrhoeae/*drug effects/isolation & purification, Ofloxacin/*pharmacology, Quality ControlEnzymology
Pathogenicity1572967Interpretive criteria and quality control limits for testing susceptibility of Neisseria gonorrhoeae to enoxacin.Barry AL, Cohen MA, Sesnie JC, Fuchs PC, Washington JA, Murray PR, Baker CJ Clin Microbiol10.1128/jcm.30.4.813-816.19921992Enoxacin/*pharmacology, Evaluation Studies as Topic, Gonorrhea/drug therapy/microbiology, Humans, Microbial Sensitivity Tests/*standards, Neisseria gonorrhoeae/*drug effects, Quality Control
Pathogenicity1939563Proposed interpretive criteria and quality control parameters for testing in vitro susceptibility of Neisseria gonorrhoeae to ciprofloxacin.Fuchs PC, Barry AL, Baker C, Murray PR, Washington JA 2ndJ Clin Microbiol10.1128/jcm.29.10.2111-2114.19911991Ciprofloxacin/*pharmacology, Drug Resistance, Microbial, Gonorrhea/drug therapy, Humans, In Vitro Techniques, Microbial Sensitivity Tests/*standards, Neisseria gonorrhoeae/*drug effects/isolation & purification, Quality Control, Staphylococcus aureus/drug effectsEnzymology
Cultivation2531756Standardization of disk diffusion and agar dilution susceptibility tests for Neisseria gonorrhoeae: interpretive criteria and quality control guidelines for ceftriaxone, penicillin, spectinomycin, and tetracycline.Jones RN, Gavan TL, Thornsberry C, Fuchs PC, Gerlach EH, Knapp JS, Murray P, Washington JA 2ndJ Clin Microbiol10.1128/jcm.27.12.2758-2766.19891989Ceftriaxone/*pharmacology, Culture Media, Microbial Sensitivity Tests/standards, Neisseria gonorrhoeae/*drug effects, Penicillins/*pharmacology, Quality Control, Spectinomycin/*pharmacology, Surveys and Questionnaires, Tetracycline/*pharmacologyPathogenicity
Pathogenicity7956017Minimum inhibitory concentration quality-control guidelines for biapenem, DU-6859a, FK-037, levofloxacin, grepafloxacin, and ceftizoxime when using various National Committee for Clinical Laboratory Standards susceptibility test methods. Quality Control Study Group.Bale MJ, Jones RN, Erwin MEDiagn Microbiol Infect Dis10.1016/0732-8893(94)90054-x1994Anti-Bacterial Agents/*pharmacology, Anti-Infective Agents/*pharmacology, Bacteria/drug effects, Ceftizoxime/analogs & derivatives/pharmacology, *Fluoroquinolones, *Levofloxacin, Microbial Sensitivity Tests/*standards, Ofloxacin/*pharmacology, Piperazines/pharmacology, Quality Control, Quinolones/pharmacology, Reference Values, Spiro Compounds/pharmacology, Thienamycins/pharmacology
Pathogenicity8408559Tentative criteria for confirming the in vitro susceptibilities of Haemophilus influenzae and Neisseria gonorrhoeae to two fluoroquinolones (sparfloxacin and levofloxacin), including quality control parameters.Barry AL, Fuchs PC, Allen SD, Jorgensen JH, Tenover FC, Murray PR, Hardy DJ, Baker CNJ Clin Microbiol10.1128/jcm.31.9.2375-2380.19931993Anti-Infective Agents/*pharmacology, *Fluoroquinolones, Haemophilus influenzae/*drug effects, *Levofloxacin, Microbial Sensitivity Tests/*standards, Neisseria gonorrhoeae/*drug effects, Ofloxacin/*pharmacology, Quality Control, Quinolones/*pharmacology
Pathogenicity8408586Quality control guidelines for cefdinir, cefepime, cefetamet, cefmetazole, cefpodoxime, cefprozil, and clinafloxacin (CI-960) for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Quality Control Study Group.Bale MJ, Jones RNJ Clin Microbiol10.1128/jcm.31.9.2538-2540.19931993Anti-Infective Agents/*pharmacology, Cefdinir, Cefepime, Cefmetazole/pharmacology, Ceftizoxime/analogs & derivatives/pharmacology, Cephalosporins/*pharmacology, *Fluoroquinolones, Humans, Microbial Sensitivity Tests/*standards, Quality Control, Quinolones/*pharmacology
Pathogenicity8647755Tentative interpretive criteria and quality control parameters for in-vitro susceptibility testing of Neisseria gonorrhoeae to two fluoroquinolones (PD 131628 and grepafloxacin (OPC 17116)).Sewell DL, Barry AL, Allen SD, Fuchs PC, Murray PR, Tenover FCJ Antimicrob Chemother10.1093/jac/37.1.1391996Anti-Infective Agents/*pharmacology, *Fluoroquinolones, Humans, Microbial Sensitivity Tests/standards, Naphthyridines/*pharmacology, Neisseria gonorrhoeae/*drug effects, Piperazines/*pharmacology, Quality Control, Quinolones/*pharmacology
Pathogenicity9147914Quality control guidelines for amoxicillin, amoxicillin-clavulanate, azithromycin, piperacillin-tazobactam, roxithromycin, ticarcillin, ticarcillin-clavulanate, trovafloxacin (CP 99,219), U-100592, and U-100766 for various National Committee for Clinical Laboratory Standards susceptibility testing methods. Results from multicenter trials.Worth S, Erwin ME, Jones RNDiagn Microbiol Infect Dis10.1016/0732-8893(95)00276-61996Acetamides/pharmacology, Amoxicillin/pharmacology, Amoxicillin-Potassium Clavulanate Combination, *Anti-Infective Agents, Azithromycin/pharmacology, Clavulanic Acids/pharmacology, *Fluoroquinolones, Humans, Linezolid, Microbial Sensitivity Tests/*standards, Naphthyridines/pharmacology, Oxazoles/pharmacology, *Oxazolidinones, Penicillanic Acid/analogs & derivatives/pharmacology, Piperacillin/pharmacology, Piperacillin, Tazobactam Drug Combination, Quality Control, Roxithromycin/pharmacology, Ticarcillin/pharmacology
Pathogenicity10887570[Antimicrobial susceptibility of Neisseria gonorrhoeae strains determined by disk diffusion].Llanes Caballero R, Acosta Giraldo JC, Sosa Puente J, Guzman Hernandez D, Gutierrez Gonzalez O, Llop Hernandez ARev Cubana Med Trop1999Bacteriological Techniques, Diffusion, Microbial Sensitivity Tests, Neisseria gonorrhoeae/*drug effects
Pathogenicity10904193Development of gemifloxacin in vitro susceptibility test methods for gonococci including quality control guidelines. The Quality Control Study Group.Jones RN, Erwin MEDiagn Microbiol Infect Dis10.1016/s0732-8893(00)00139-52000Anti-Infective Agents/*pharmacology, Ciprofloxacin/pharmacology, Colony Count, Microbial, *Fluoroquinolones, Gemifloxacin, Microbial Sensitivity Tests/methods, Naphthyridines/*pharmacology, Neisseria gonorrhoeae/*drug effects, Quality Control, Reference Standards, Reproducibility of Results
Phylogeny15950072Evaluation of the BIOCEN GC agar medium base in antimicrobial susceptibility testing of Neisseria gonorrhoeae.Llanes R, Dominguez C, Prat A, Rodriguez C, Valdes EA, Gutierrez O, Guzman DArch Med Res10.1016/j.arcmed.2005.03.0112005Agar/*chemistry, Anti-Bacterial Agents/pharmacology, Anti-Infective Agents/*pharmacology, *Bacteriological Techniques, Cuba, *Drug Resistance, Microbial, *Microbial Sensitivity Tests, Neisseria gonorrhoeae/*metabolism, Reproducibility of Results, Species SpecificityMetabolism
Pathogenicity16410969Studies on antimicrobial activity, in vitro, of Physalis angulata L. (Solanaceae) fraction and physalin B bringing out the importance of assay determination.Silva MT, Simas SM, Batista TG, Cardarelli P, Tomassini TCMem Inst Oswaldo Cruz10.1590/s0074-027620050007000182006Agar, Anti-Bacterial Agents/*therapeutic use, Candida albicans/*drug effects, Culture Media, Drug Evaluation, Preclinical, Gram-Negative Bacteria/*drug effects, Gram-Positive Bacteria/*drug effects, Lactones/*therapeutic use, Microbial Sensitivity Tests/methods, *Physalis, Plant Extracts/pharmacology, Secosteroids, Steroids/*therapeutic useCultivation
Cultivation17494717Comparative in vitro antimicrobial activity of tigecycline, a new glycylcycline compound, in freshly prepared medium and quality control.Brown SD, Traczewski MMJ Clin Microbiol10.1128/JCM.02351-062007Anti-Bacterial Agents/*pharmacology, Bacteria/*drug effects, Culture Media, Drug Resistance, Bacterial, Microbial Sensitivity Tests, Minocycline/*analogs & derivatives/pharmacology, Quality Control, Tetracycline/*pharmacology, TigecyclinePathogenicity
Enzymology19429310In vitro antigonococcal activity of Coscinium fenestratum stem extract.Chomnawang MT, Trinapakul C, Gritsanapan WJ Ethnopharmacol10.1016/j.jep.2009.01.0362009Animals, Anti-Bacterial Agents/isolation & purification/*pharmacology/therapeutic use, Berberine/isolation & purification/*pharmacology/therapeutic use, Gonorrhea/*drug therapy/microbiology, Magnoliopsida/*chemistry, Medicine, East Asian Traditional, Medicine, Traditional, Menispermaceae/chemistry, Mice, Microbial Sensitivity Tests, Neisseria gonorrhoeae/*drug effects, Phytotherapy, Plant Extracts/chemistry/*pharmacology/therapeutic use, Plant Stems, Plants, MedicinalPhylogeny
Pathogenicity19460783Evaluation of the mutant selection window for fluoroquinolones against Neisseria gonorrhoeae.Allen GP, Hankins CDJ Antimicrob Chemother10.1093/jac/dkp1722009Anti-Bacterial Agents/*pharmacology, Aza Compounds/pharmacology, Ciprofloxacin/pharmacology, *Drug Resistance, Bacterial, Fluoroquinolones/*pharmacology, Levofloxacin, Microbial Sensitivity Tests, Moxifloxacin, *Mutation, Neisseria gonorrhoeae/*drug effects, Ofloxacin/pharmacology, Quinolines/pharmacology, *Selection, Genetic
Pathogenicity21844727Resistance to azithromycin of Neisseria gonorrhoeae isolates from 2 cities in China.Yuan LF, Yin YP, Dai XQ, Pearline RV, Xiang Z, Unemo M, Chen XSSex Transm Dis10.1097/OLQ.0b013e318219cdb52011Anti-Bacterial Agents/pharmacology, Azithromycin/*pharmacology, Ceftriaxone/pharmacology, China/epidemiology, Ciprofloxacin/pharmacology, Drug Resistance, Bacterial/drug effects/genetics, Female, Gonorrhea/drug therapy/epidemiology/*microbiology, Humans, Microbial Sensitivity Tests, Molecular Epidemiology, Multilocus Sequence Typing, Neisseria gonorrhoeae/*drug effects/genetics/isolation & purification, Spectinomycin/pharmacology, Tetracycline/pharmacology, Urban Population/statistics & numerical dataEnzymology
21941568Increasing Trend of Resistance to Penicillin, Tetracycline, and Fluoroquinolone Resistance in Neisseria gonorrhoeae from Pakistan (1992-2009).Jabeen K, Nizamuddin S, Irfan S, Khan E, Malik F, Zafar AJ Trop Med10.1155/2011/9605012011
Pathogenicity23705013Non-cytotoxic nanomaterials enhance antimicrobial activities of cefmetazole against multidrug-resistant Neisseria gonorrhoeae.Li LH, Yen MY, Ho CC, Wu P, Wang CC, Maurya PK, Chen PS, Chen W, Hsieh WY, Chen HWPLoS One10.1371/journal.pone.00647942013Anti-Infective Agents/*pharmacology, Cefmetazole/*pharmacology, Cell Death/drug effects, Cell Line, Drug Carriers/chemistry, Drug Resistance, Multiple, Bacterial/*drug effects, Epithelial Cells/cytology/drug effects, Fibroblasts/cytology/drug effects, Humans, Ions, Metal Nanoparticles/chemistry/toxicity/ultrastructure, Microbial Sensitivity Tests, Models, Biological, Nanostructures/chemistry/*toxicity/ultrastructure, Neisseria gonorrhoeae/*drug effects/isolation & purification, Particle Size, Silver/pharmacologyEnzymology
Pathogenicity24207077Coupling electrochemical response of a DNA biosensor with PCR for Neisseria gonorrhoeae detection.Verma R, Sood S, Singh R, Sumana G, Bala M, Sharma VK, Samantaray JC, Pandey RM, Malhotra BDDiagn Microbiol Infect Dis10.1016/j.diagmicrobio.2013.09.0102013Adolescent, Adult, Biosensing Techniques/*methods, Diagnostic Tests, Routine/*methods, Early Diagnosis, Electrochemical Techniques/*methods, Female, Gonorrhea/*diagnosis, Humans, Male, Middle Aged, Neisseria gonorrhoeae/genetics/*isolation & purification, Polymerase Chain Reaction/*methods, Predictive Value of Tests, Sensitivity and Specificity, Young AdultEnzymology
Pathogenicity25547354In vitro activity of fosfomycin alone and in combination with ceftriaxone or azithromycin against clinical Neisseria gonorrhoeae isolates.Hauser C, Hirzberger L, Unemo M, Furrer H, Endimiani AAntimicrob Agents Chemother10.1128/AAC.04536-142014Anti-Bacterial Agents/*pharmacology, Azithromycin/*pharmacology, Ceftriaxone/*pharmacology, Drug Therapy, Combination/methods, Fosfomycin/*pharmacology, Gonorrhea/drug therapy/microbiology, Humans, Microbial Sensitivity Tests/methods, Neisseria gonorrhoeae/*drug effects
Pathogenicity26378286Determination of Disk Diffusion and MIC Quality Control Guidelines for Solithromycin, a Novel Fluoroketolide Antibacterial, against Neisseria gonorrhoeae.Riedel S, Ross JE, Farrell DJ, Flamm RK, Jones RNJ Clin Microbiol10.1128/JCM.02250-152015Anti-Bacterial Agents/*pharmacology, Humans, Macrolides/*pharmacology, Microbial Sensitivity Tests/*standards, Neisseria gonorrhoeae/*drug effects, Quality Control, Triazoles/*pharmacology
Pathogenicity26603424In vitro potency and combination testing of antimicrobial agents against Neisseria gonorrhoeae.Bharat A, Martin I, Zhanel GG, Mulvey MRJ Infect Chemother10.1016/j.jiac.2015.10.0022015Anti-Infective Agents/*pharmacology, *Drug Resistance, Bacterial, *Drug Synergism, Drug Therapy, Combination, Gonorrhea/microbiology, Humans, Microbial Sensitivity Tests/*methods, Neisseria gonorrhoeae/*drug effects
Pathogenicity27161642Multicenter Investigation of Gepotidacin (GSK2140944) Agar Dilution Quality Control Determinations for Neisseria gonorrhoeae ATCC 49226.Jones RN, Fedler KA, Scangarella-Oman NE, Ross JE, Flamm RKAntimicrob Agents Chemother10.1128/AAC.00527-162016Acenaphthenes/*pharmacology, Anti-Bacterial Agents/*pharmacology, Gonorrhea/*microbiology, Heterocyclic Compounds, 3-Ring/*pharmacology, Microbial Sensitivity Tests, Neisseria gonorrhoeae/*drug effects, Topoisomerase Inhibitors/*pharmacology
Genetics27449234Antimicrobial resistance and Neisseria gonorrhoeae multiantigen sequence typing (NG-MAST) genotypes in N. gonorrhoeae during 2012-2014 in Karachi, Pakistan.Jabeen K, Bhawan Mal P, Khan E, Chandio S, Jacobsson S, Unemo MBMC Infect Dis10.1186/s12879-016-1673-12016Adolescent, Adult, Anti-Bacterial Agents/*pharmacology, Child, Child, Preschool, DNA, Bacterial/analysis, *Drug Resistance, Bacterial, Female, *Genotype, Genotyping Techniques, Gonorrhea/diagnosis/epidemiology/*microbiology, Humans, Infant, Male, Microbial Sensitivity Tests, Middle Aged, Molecular Epidemiology, Neisseria gonorrhoeae/*drug effects/*genetics/isolation & purification, Pakistan/epidemiology, Prevalence, Young AdultPathogenicity
Cultivation31315953Determination of MIC Quality Control Ranges for the Novel Gyrase Inhibitor Zoliflodacin.Miller AA, Traczewski MM, Huband MD, Bradford PA, Mueller JPJ Clin Microbiol10.1128/JCM.00567-192019Anti-Bacterial Agents/*pharmacology, Barbiturates/*pharmacology, Culture Media, Enzyme Inhibitors/*pharmacology, Gram-Negative Bacteria/*drug effects, Gram-Positive Bacteria/*drug effects, Isoxazoles, Microbial Sensitivity Tests/*methods/*standards, Morpholines, Oxazolidinones, Quality Control, Spiro Compounds/*pharmacologyPathogenicity
Metabolism32140142Comparative Proteomics of Extended-Spectrum Cephalosporin-Resistant Neisseria gonorrhoeae Isolates Demonstrates Altered Protein Synthesis, Metabolism, Substance Transport, and Membrane Permeability.Diao N, Yan G, Yang Y, Dong Y, Wang Y, Gu WFront Microbiol10.3389/fmicb.2020.001692020
Pathogenicity32830243Octenidine/carbenicillin GUMBOS as potential treatment for oropharyngeal gonorrhoea.Lopez KM, Hobden JA, Warner IMJ Antimicrob Chemother10.1093/jac/dkaa3462020Anti-Bacterial Agents/pharmacology/therapeutic use, Carbenicillin, *Gonorrhea/drug therapy, HeLa Cells, Humans, Imines, Neisseria gonorrhoeae, Pyridines, Salts
33558293In Vitro and In Vivo Activities of TP0480066, a Novel Topoisomerase Inhibitor, against Neisseria gonorrhoeae.Masuko A, Takata I, Fujita K, Okumura H, Ushiyama F, Amada H, Sugiyama HAntimicrob Agents Chemother10.1128/AAC.02145-202021Animals, Anti-Bacterial Agents/pharmacology, DNA Gyrase/genetics, DNA Topoisomerase IV/genetics, Drug Resistance, Bacterial, Fluoroquinolones, *Gonorrhea/drug therapy, Mice, Microbial Sensitivity Tests, *Neisseria gonorrhoeae
Pathogenicity34391903In vitro evaluation of antimicrobial resistance selection in Neisseria gonorrhoeae.Allen GP, Deao KM, Hill SA, Schipelliti SM, Tran TInt J Antimicrob Agents10.1016/j.ijantimicag.2021.1064172021Anti-Bacterial Agents/*pharmacology, Azithromycin/pharmacology, Ceftriaxone/pharmacology, Ciprofloxacin/pharmacology, Doxycycline/pharmacology, Drug Resistance, Multiple, Bacterial/*genetics, Ertapenem/pharmacology, Gentamicins/pharmacology, Gonorrhea/*drug therapy, Humans, Levofloxacin/pharmacology, Microbial Sensitivity Tests, Moxifloxacin/pharmacology, Neisseria gonorrhoeae/*drug effects/genetics
Pathogenicity36350125Antimicrobial Activity of Auranofin, Cannabidivarin, and Tolfenamic Acid against Multidrug-Resistant Neisseria gonorrhoeae.Yang F, Liu J, Gu Y, Jiao R, Yan J, Gao S, Lin X, van der Veen SMicrobiol Spectr10.1128/spectrum.03952-222022

Reference

@idauthorscataloguedoi/urltitlejournalpubmed
3508Curators of the DSMZLeibniz Institut DSMZ-Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH (DSM 9189)https://www.dsmz.de/collection/catalogue/details/culture/DSM-9189
20215Parte, A.C., Sardà Carbasse, J., Meier-Kolthoff, J.P., Reimer, L.C. and Göker, M.10.1099/ijsem.0.004332List of Prokaryotic names with Standing in Nomenclature (LPSN) moves to the DSMZ
20218Verslyppe, B., De Smet, W., De Baets, B., De Vos, P., Dawyndt P.10.1016/j.syapm.2013.11.002StrainInfo introduces electronic passports for microorganisms.Syst Appl Microbiol. 37: 42-50 201424321274
36023Curators of the CIPhttps://brclims.pasteur.fr/brcWeb/souche/detail/1/19227
48390Curators of the CCUGCulture Collection University of Gothenburg (CCUG) (CCUG 26213)https://www.ccug.se/strain?id=26213
66792Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesAutomatically annotated for the DiASPora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
68377Automatically annotated from API NH
68382Automatically annotated from API zym
69479João F Matias Rodrigues, Janko Tackmann,Gregor Rot, Thomas SB Schmidt, Lukas Malfertheiner, Mihai Danaila,Marija Dmitrijeva, Daniela Gaio, Nicolas Näpflin and Christian von Mering. University of Zurich.https://microbeatlas.org/MicrobeAtlas 1.0 beta
69480Julia Koblitz, Joaquim Sardà, Lorenz Christian Reimer, Boyke Bunk, Jörg Overmannhttps://diaspora-project.de/progress.html#genomesPredictions based on genome sequence made in the Diaspora project (Digital Approaches for the Synthesis of Poorly Accessible Biodiversity Information)
69481Xiao-Yin To, René Mreches, Martin Binder, Alice C. McHardy, Philipp C. Münch10.21203/rs.3.rs-2527258/v1Predictions based on the model GenomeNet Sporulation v. 1
79748Reimer, L.C., Lissin, A.,Schober, I., Witte,J.F., Podstawka, A., Lüken, H., Bunk, B.,Overmann, J.10.60712/SI-ID42367.1StrainInfo: A central database for resolving microbial strain identifiers
119706Curators of the CIPCollection of Institut Pasteur (CIP 107031)https://catalogue-crbip.pasteur.fr/fiche_catalogue.xhtml?crbip=CIP%20107031